| Citation: | MENG Fankai, TAN Xiyou, LI Chunrui, HUANG Lifang, LIU Wenli, ZHOU Jianfeng, SUN Hanying. Molecular Cloning and Function Analysis of Human Cyclin D3 Gene Promoter Region in A2780 Cells[J]. Cancer Research on Prevention and Treatment, 2014, 41(01): 9-12. DOI: 10.3971/j.issn.1000-8578.2014.01.003 |
| [1] |
Rosen DG, Yang G, Liu G, et al. Ovarian cancer: pathology, biology, and disease models [J]. Front Biosci, 2009, 14:2089-102.
|
| [2] |
Zhang SW,Chen WQ,Wei W,et al.Ovary cancer mortality in China 20 04-2005: results from the third national retrospective sampling survey of death causes[J].Zhonghua Yu Fang Yi Xue Za Zhi, 20 10,44(5):418-22.[张思维,陈万青,魏文,等.中国第三次死因抽 样调查(2004-2005)卵巢癌死亡情况分析[J].中华预防医学杂 志,2010,44(5):418-22.]
|
| [3] |
Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression[J]. Genes Dev, 1999, 13 (12):1501-12.
|
| [4] |
Blain SW. Switching cyclin D-Cdk4 kinase activity on and off [J]. Cell Cycle, 2008, 7(7):892-8.
|
| [5] |
Masamha CP, Benbrook DM. Cyclin D1 degradation is suffi cient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells[J]. Cancer Res, 2009, 69 (16):6565-72.
|
| [6] |
Wang Z,Zhang Y,Lu J,et al.Mpl ligand enhances the transcription of the cyclin D3 gene: a potential role for Sp1 transcription factor[J]. Blood, 1999, 93(12):4208-21.
|
| [7] |
Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control[J]. Trends Cell Biol, 2007, 17(7):318-24.
|
| [8] |
Vesely PW, Staber PB, Hoefl er G, et al. Translational regulation mechanisms of AP-1 proteins [J]. Mutat Res, 2009, 682(1):7-12.
|
| [9] |
Lecomte S, Desmots F, Le Masson F, et al. Roles of heat shock factor 1 and 2 in response to proteasome inhibition: consequence on p53 stability[J]. Oncogene, 2010, 29(29):4216-24.
|
| [10] |
Mudduluru G, Vajkoczy P, Allgayer H. Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer [J]. Mol Cancer Res, 2010, 8( 2):159-69.
|
| [11] |
Previdi S, Malek A, Albertini V, et al. Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts[J]. Gynecol Oncol, 2010, 118(2):182-8.
|
| [1] | Chen QIN, Pei-yuan QIU, Qian-han DENG, Li LI. LIPG expression in ovarian cancer is associated with platinum resistance and prognosis[J]. Cancer Research on Prevention and Treatment. DOI: 10.3971/j.issn.1000-8578.2026.25.0430 |
| [2] | YANG Danni, ZHAO Mengna, FENG Xiaoye, TONG Jiyu, WANG Hua, CAI Hongbing. Value of Inflammatory Load in Predicting Prognosis of Elderly Patients with Epithelial Ovarian Cancer[J]. Cancer Research on Prevention and Treatment, 2024, 51(5): 361-367. DOI: 10.3971/j.issn.1000-8578.2024.23.1174 |
| [3] | TAN Fangchun, LI Li. Review of Molecular Subtyping of Ovarian Cancer and Its Clinical Application[J]. Cancer Research on Prevention and Treatment, 2018, 45(2): 106-109. DOI: 10.3971/j.issn.1000-8578.2018.17.0771 |
| [4] | ZHENG Haiyan, RUAN Jian, PAN Linglan, LIU Jianqiao. Cathepsin L Promotes Invasion and Migration of Human Ovarian Cancer Cell Line SKOV3[J]. Cancer Research on Prevention and Treatment, 2015, 42(06): 556-559. DOI: 10.3971/j.issn.1000-8578.2015.06.005 |
| [5] | FAN Bei, LI Hongxia, WU Yumei, ZHAO Qun, DENG Xiaohong. Biological Characteristics of Paclitaxel-resistance Ovarian Cancer Cell Lines and Cryopreservation Methods[J]. Cancer Research on Prevention and Treatment, 2015, 42(04): 334-339. DOI: 10.3971/j.issn.1000-8578.2015.04.004 |
| [6] | ZHONG Yanping, MENG Yongzhen, LI Li, YIN Fuqiang, LI Danrong, ZHANG Wei. Biological Characteristics of Side Population Cells in Ovarian Cancer Cell Line SKOV3[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1282-1285. DOI: 10.3971/j.issn.1000-8578.2014.12.006 |
| [7] | YANG Zongyuan, SUN Chaoyang, ZHOU Bo, LI Na, HE Yang, DING Dong, CHEN Gang, ZHU Tao. MicroRNA-107 Targeting Dicer1 for Metastasis Control in Ovarian Cancer Cell Lines[J]. Cancer Research on Prevention and Treatment, 2013, 40(07): 660-666. DOI: 10.3971/j.issn.1000-8578.2013.07.008 |
| [8] | TIAN Xun, WANG Wei, XING Hui, XU Qian, LI Fu-jun, LU Yun-ping, WANG Shi-xuan, MA Ding. Molecular Mechanism of Apoptosis in Cisplatin-resistant Human Ovarian Cancer Cell Line Promoted by Topotecan[J]. Cancer Research on Prevention and Treatment, 2005, 32(06): 360-363. DOI: 10.3971/j.issn.1000-8578.646 |
| [9] | DENG An-mei, ZHONG Ren-qian, CHEN Sun-xiao, et al, . United detection of tumor markers in patients with ovarian cancer with protein chip[J]. Cancer Research on Prevention and Treatment, 2002, 29(06): 475-476. DOI: 10.3971/j.issn.1000-8578.1290 |
| [10] | Dong Yuelan, Li Lin, Chen Lixin. The Relatonship Between the Expression of P16 in Ovarian Cancer and Clinical Stages[J]. Cancer Research on Prevention and Treatment, 1999, 26(2): 109-110. |